Igc Pharma Inc
(IGC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2020 | 03-2019 | 03-2018 | 03-2017 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,258 | 25,610 | 1,658 | 538 | 1,491 |
| Marketable Securities | 5,081 | N/A | 148 | 1,880 | 0 |
| Receivables | 133 | 84 | 558 | 753 | 963 |
| Inventories | 4,245 | 248 | 486 | 0 | 162 |
| Other current assets | 1,040 | 781 | 355 | 411 | 0 |
| TOTAL | $17,757 | $26,723 | $3,205 | $3,581 | $3,842 |
| Non-Current Assets | |||||
| PPE Net | 9,780 | 5,886 | 6,237 | 954 | 7,074 |
| Investments And Advances | 11 | 794 | 799 | 6,011 | 5,785 |
| Intangibles | 252 | 184 | 128 | 198 | 1,294 |
| Other Non-Current Assets | 1,184 | 878 | 484 | 540 | 864 |
| TOTAL | $11,227 | $7,742 | $7,648 | $7,703 | $15,017 |
| Total Assets | $28,984 | $34,465 | $10,853 | $11,284 | $18,859 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 50 | 50 | 0 | N/A | 217 |
| Accounts payable and accrued liabilities | 762 | 319 | 258 | 417 | 331 |
| Accrued Expenses | 1,134 | 509 | 288 | N/A | 300 |
| Other current liabilities | N/A | N/A | N/A | 873 | 551 |
| TOTAL | $1,946 | $878 | $2,346 | $1,290 | $3,199 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 427 | 2,644 | 802 |
| Other Non-Current Liabilities | 501 | 15 | 15 | -14 | 936 |
| TOTAL | $501 | $15 | $442 | $2,644 | $1,712 |
| Total Liabilities | $2,447 | $893 | $2,788 | $3,934 | $4,911 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 41,186 | 39,511 | 31,028 | 30,572 | 23,336 |
| Common Shares | 94,754 | 94,043 | 63,917 | 3 | 2 |
| Retained earnings | -65,367 | -58,052 | -53,795 | -52,010 | -50,142 |
| Other shareholders' equity | -2,850 | -2,419 | -2,057 | -2,057 | -1,797 |
| TOTAL | $26,537 | $33,572 | $8,065 | $7,350 | $13,948 |
| Total Liabilities And Equity | $28,984 | $34,465 | $10,853 | $11,284 | $18,859 |